Investors
The Leukemia & Lymphoma Society’s Therapy Acceleration Program

The Leukemia & Lymphoma Society’s Therapy Acceleration Program

https://lls.org

The Leukemia & Lymphoma Society’s Therapy Acceleration Program (TAP) is a venture capital fund targeting the biotech and health tech sectors to combat blood cancers. TAP funds companies focused on cancer research, aiming to transform lab discoveries into practical patient solutions. Notable investments include Enterome. By driving the development of new therapies, TAP strives to accelerate the availability of effective treatments for blood cancer patients.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Recent Investments